# A First Time In Human Study To Assess The Compound GSK615915

> **NCT00400660** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 46 (actual)

## Conditions studied

- Bronchospasm

## Interventions

- **DRUG:** GSK615915A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00400660
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-23
- **Primary completion:** 2006-07-03
- **Final completion:** 2006-07-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400660, "A First Time In Human Study To Assess The Compound GSK615915". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT00400660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*